Home Healthcare Medical Devices Novel Drug Delivery System Market

Novel Drug Delivery System Market Size, Share & Trends Analysis Report By Route of Administration (Oral Drug, Injectable Drug, Pulmonary Drug, Transdermal Drug, Others), By Mode of NDSS (Targeted, Controlled, Modulated) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format: | Report Code: SR2559DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Novel Drug Delivery System Market Size Analysis
    1. Introduction
    2. Novel Drug Delivery System Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral Drug
      2. Injectable Drug
      3. Pulmonary Drug
      4. Transdermal Drug
      5. Others
    3. Novel Drug Delivery System Market Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
      1. Targeted
      2. Controlled
      3. Modulated
  7. North America Novel Drug Delivery System Market Size Analysis
    1. Introduction
    2. Novel Drug Delivery System Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral Drug
      2. Injectable Drug
      3. Pulmonary Drug
      4. Transdermal Drug
      5. Others
    3. Novel Drug Delivery System Market Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
      1. Targeted
      2. Controlled
      3. Modulated
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
  8. Europe Novel Drug Delivery System Market Size Analysis
    1. Introduction
    2. Novel Drug Delivery System Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral Drug
      2. Injectable Drug
      3. Pulmonary Drug
      4. Transdermal Drug
      5. Others
    3. Novel Drug Delivery System Market Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
      1. Targeted
      2. Controlled
      3. Modulated
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    6. France
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
  9. APAC Novel Drug Delivery System Market Size Analysis
    1. Introduction
    2. Novel Drug Delivery System Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral Drug
      2. Injectable Drug
      3. Pulmonary Drug
      4. Transdermal Drug
      5. Others
    3. Novel Drug Delivery System Market Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
      1. Targeted
      2. Controlled
      3. Modulated
    4. China
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    7. India
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
  10. Middle East and Africa Novel Drug Delivery System Market Size Analysis
    1. Introduction
    2. Novel Drug Delivery System Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral Drug
      2. Injectable Drug
      3. Pulmonary Drug
      4. Transdermal Drug
      5. Others
    3. Novel Drug Delivery System Market Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
      1. Targeted
      2. Controlled
      3. Modulated
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
  11. LATAM Novel Drug Delivery System Market Size Analysis
    1. Introduction
    2. Novel Drug Delivery System Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral Drug
      2. Injectable Drug
      3. Pulmonary Drug
      4. Transdermal Drug
      5. Others
    3. Novel Drug Delivery System Market Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
      1. Targeted
      2. Controlled
      3. Modulated
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral Drug
        2. Injectable Drug
        3. Pulmonary Drug
        4. Transdermal Drug
        5. Others
      3. Market Size & Forecast By Mode of NDSS 2022-2034 (USD MILLION/ Units)
        1. Targeted
        2. Controlled
        3. Modulated
  12. Competitive Landscape
    1. Novel Drug Delivery System Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca PLC
    3. Bayer AG.
    4. Hoffmann-La Roche AG
    5. GlaxoSmithKline PLC
    6. Johnson & Johnson
    7. Merck & Co. Inc.
    8. Novartis AG
    9. Pfizer Inc.
    10. Sanofi SA.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.